研究单位：[1]Cancer Institute and Hospital, Chinese Academy of Medical Sciences[2]China-Japan Friendship Hospital[3]Peking University Cancer Hospital & Institute[4]Beijing Chao Yang Hospital[5]Peking University Third Hospital[6]The Second People's Hospital of Sichuan[7]First Affiliated Hospital of Chongqing Medical University[8]Hunan Cancer Hospital[9]The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China[10]First Hospital of China Medical University[11]Quanzhou First Hospital[12]Jiangxi Provincial People's Hopital[13]People's Hospital of Guangxi[14]Cancer Hospital of Chinese Academy of Medical Science,Beijing,Beijing,China,100021[15]China-japan friendship hospital,Beijing,Beijing,China,100029[16]Peking University Cancer Hospital,Beijing,Beijing,China,100142[17]Peking University Third Hospital,Beijing,Beijing,China,100191[18]Beijing Chao-Yang Hospital,Beijing,Beijing,China,10020[19]The First Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China,630014[20]Quanzhou First Hospital,Quanzhou,Fujian,China,362002[21]The People's Hospital Of Guangxi Zhuang Autonomous Region,Nanning,Guangxi,China,530021[22]Hunan Cancer Hospital,Changsha,Hunan,China,410013[23]Nantong Tumor Hospital,Nantong,Jiangsu,China,226361[24]Jiangxi Provincial People''s Hospital,Nanchang,Jiangxi,China,330006[25]The First Hospital of China Medical University,Shenyang,Liaoning,China,110001[26]The Second People's Hospital of Sichuan,Chengdu,Sichuan,China,610041
This study is a multi-center, randomized, and open-label trial to compare the safety and feasibility of traditional three incisions and minimally invasive thoracol-laparoscopic esophagectomy for esophageal cancer.
